Kaneka Completes Acquisition of Japan Medical Device Technology

Thursday, December 07, 2023

Kaneka Corporation has successfully acquired full ownership of Japan Medical Device Technology, a prominent developer and manufacturer of medical devices. Kaneka specializes in the production and sale of endovascular catheters, crucial in treating cardiac, peripheral vascular, and cerebrovascular diseases. Notably, with a market value of 30 billion yen in Japan, Kaneka aims to expand its presence in the coronary artery disease treatment sector, particularly in the field of stenting.

Japan Medical Device Technology possesses advanced technological capabilities, particularly in the research and development of coronary stents, establishing itself as a key player in the advancement of bioresorbable stents. Traditional coronary artery treatment involves placing a metallic mesh stent at the lesion site to expand the lumen and restore blood flow. However, the challenge arises when considering restenosis, as placing another stent in the same location becomes problematic due to the presence of the initial stent.

JMDT's groundbreaking bioresorbable stent, crafted from a biodegradable magnesium alloy, addresses this concern by preventing vessel blockage associated with a lingering stent. Remarkably, 95% of the stent is naturally absorbed by the body 1.5 years after implantation, ensuring it does not impede the treatment of restenosis. This innovative approach heralds a significant leap forward in coronary artery disease management, aligning with Kaneka's strategic vision for expanding its influence in this crucial medical domain.

Source: businesswire.com